当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 现金流量表

科华生物

(002022)

  

流通市值:29.42亿  总市值:29.42亿
流通股本:5.14亿   总股本:5.14亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金819,044,600.09379,425,042.731,868,325,054.151,375,566,176.82
  收到的税费返还53,872,432.055,122,909.411,837,220.82889,009.85
  收到其他与经营活动有关的现金16,205,705.315,110,329.147,651,495.3432,114,681.56
  经营活动现金流入小计889,122,737.45389,658,281.241,917,813,770.311,408,569,868.23
  购买商品、接受劳务支付的现金509,443,938.45252,100,875.29976,696,203.78743,388,116.94
  支付给职工以及为职工支付的现金249,065,524.71136,710,222.56489,025,221.42384,225,815.11
  支付的各项税费29,201,276.1112,026,357.5355,470,658.543,000,398.01
  支付其他与经营活动有关的现金155,861,172.9291,183,883.63374,183,021.23262,052,519.52
  经营活动现金流出小计943,571,912.19492,021,339.011,895,375,104.931,432,666,849.58
  经营活动产生的现金流量净额-54,449,174.74-102,363,057.7722,438,665.38-24,096,981.35
二、投资活动产生的现金流量:
  收回投资收到的现金60,000,00060,000,000--
  取得投资收益收到的现金2,085,021.811,132,217.782,038,529.931,354,770.8
  处置固定资产、无形资产和其他长期资产收回的现金净额3,835,989.652,034,241.248,099,734.384,954,381.53
  处置子公司及其他营业单位收到的现金净额963,213.28463,213.281,500,0001,000,000
  投资活动现金流入小计66,884,224.7463,629,672.311,638,264.317,309,152.33
  购建固定资产、无形资产和其他长期资产支付的现金58,600,050.9121,822,356.82139,293,855.3896,368,018.83
  投资支付的现金2,100,0002,100,00060,000,000-
  投资活动现金流出小计60,700,050.9123,922,356.82199,293,855.3896,368,018.83
  投资活动产生的现金流量净额6,184,173.8339,707,315.48-187,655,591.07-89,058,866.5
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,250,0002,250,000
  其中:子公司吸收少数股东投资收到的现金--2,250,0002,250,000
  取得借款收到的现金304,551,215.92134,496,697.9611,920,500.57378,539,640.48
  收到其他与筹资活动有关的现金18,847,852.43-37,003,419.55-
  筹资活动现金流入小计323,399,068.35134,496,697.9651,173,920.12380,789,640.48
  偿还债务支付的现金259,818,969.81119,440,340.28403,316,268.52187,953,239.02
  分配股利、利润或偿付利息支付的现金9,821,392.534,653,610.1765,642,516.3461,444,204.74
  其中:子公司支付给少数股东的股利、利润3,612,000-50,197,00050,197,000
  支付其他与筹资活动有关的现金27,235,639.273,762,393.8324,934,036.6410,222,073.81
  筹资活动现金流出小计296,876,001.61127,856,344.28493,892,821.5259,619,517.57
  筹资活动产生的现金流量净额26,523,066.746,640,353.62157,281,098.62121,170,122.91
四、汇率变动对现金及现金等价物的影响-6,342,369.79-1,320,334.43732,215.21-606,958.05
五、现金及现金等价物净增加额-28,084,303.96-57,335,723.1-7,203,611.867,407,317.01
  加:期初现金及现金等价物余额853,173,646.06853,173,646.06860,377,257.92860,377,257.92
  期末现金及现金等价物余额825,089,342.1795,837,922.96853,173,646.06867,784,574.93
补充资料:
  净利润-95,243,225.66--884,793,893.44-
  资产减值准备15,151,711.48-305,448,001.29-
  固定资产和投资性房地产折旧54,049,813-128,017,469.4-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧54,049,813-128,017,469.4-
  无形资产摊销30,589,822.06-83,941,322.01-
  长期待摊费用摊销3,908,853.68-21,113,117.96-
  处置固定资产、无形资产和其他长期资产的损失-1,279,940.73--3,869,704.67-
  固定资产报废损失242,097.86-2,839,379.44-
  公允价值变动损失43,234.35--32,174.4-
  财务费用13,585,196.21-21,001,224.93-
  投资损失-2,546,207.52--1,686,331.97-
  递延所得税-388,369.6-58,518,007.93-
  其中:递延所得税资产减少69,444.29-60,030,776.11-
    递延所得税负债增加-457,813.89--1,512,768.18-
  存货的减少15,504,484.14--5,211,881.26-
  经营性应收项目的减少-20,667,658.29-76,356,619.51-
  经营性应付项目的增加-86,038,706.18-40,882,898.38-
  一年内到期的可转换公司债券224,441,500-221,497,989.83-
  现金的期末余额825,089,342.1-853,173,646.06-
  减:现金的期初余额853,173,646.06-860,377,257.92-
  现金及现金等价物的净增加额-28,084,303.96--7,203,611.86-
公告日期2026-08-282026-04-282026-04-172025-10-30
审计意见(境内)标准无保留意见
TOP↑